98 studies found for:    Open Studies | "Heparin"
Show Display Options
Rank Status Study
21 Recruiting Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: Heparin;   Drug: Nadroparin;   Drug: Placebo
22 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
23 Unknown  Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP
24 Unknown  Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
Condition: Coronary Artery Disease
Intervention: Procedure: Percutaneous Coronary Intervention (PCI)
25 Recruiting Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Conditions: Inhalation Injury;   Burn Injury
Interventions: Drug: unfractionated heparin;   Drug: placebo
26 Recruiting The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: Nadroparin;   Drug: Placebo
27 Recruiting Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin
28 Unknown  Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
29 Unknown  Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Biological: heparin sodium
30 Unknown  Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
31 Unknown  The Role of Low Molecular Weight Heparins (LMWH) Combined With Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: LMWH;   Procedure: TACE
32 Recruiting Clinical Outcomes About Heparin Surface Modified Aspheric Lens
Condition: Inflammatory Reaction
Interventions: Device: traditional lens;   Device: heparin surface modified aspheric lens
33 Recruiting The Use of Low Molecular Weight Heparin in Hemodiafiltration
Condition: Chronic Kidney Disease
Interventions: Procedure: At start of the session, at the inlet line;   Procedure: 5 minutes after the start of the session, at the inlet line;   Procedure: At the start of the session, at the outlet line
34 Recruiting Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
Condition: Thrombosis
Intervention: Drug: Heparin
35 Recruiting Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
Conditions: Venous Thrombosis;   Pulmonary Embolism
Intervention: Drug: Enoxaparin
36 Unknown  Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
Condition: Coronary Artery Disease
Interventions: Drug: Bivalirudin;   Drug: Heparin
37 Unknown  Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients
Conditions: Cancer;   Thrombosis;   Angina Pectoris;   Advanced Solid Malignancy
Intervention:
38 Recruiting Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
Condition: Septic Shock
Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation);   Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)
39 Unknown  Impact of Heparin on the Need for Mechanical Ventilation in Neonates
Conditions: Respiration, Artificial;   Hemorrhage
Intervention: Drug: heparin
40 Unknown  Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?
Condition: Fetal Growth Retardation
Interventions: Drug: Innohep (Tinzaparin);   Drug: tinzaparin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years